Glioma cell stemness is promoted through the activation of transcription factors SRY-Box Transcription Factor-2 (Sox2) and Octamer-Binding Transcription Factor-4 (Oct4) in GSCs, thus stimulating several mechanisms that inhibit innate and adaptive immune responses supporting GBMs’ immunosuppressive state [133]. The gene discussed is SOX2; the disease is glioma.